From: An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma
Treatment | Effects on tumor | Side-effects on HCC patients | Reference |
---|---|---|---|
PEI | Tumor necrosis | High local recurrence rate | |
Acetic acid acetic injection | Glypican-3, RFA | Lower survival outcome of patients | [14] |
RFA | Thermal injury to the cancer tissue | Increased risk of local tumor progression and incomplete ablation | |
MWA | Tumor destruction | High local recurrence rate | [27] |
Cryoablation | Tumor necrosis | Severe coagulopathy | [29] |
Laser Ablation | Tumor necrosis | Lower survival outcome of patients | [28] |
IRE | Cancer tissue death | High local recurrence rate | |
Yttrium-90 Radioembolization | Tumor necrosis Cancer tissue death Apoptotic cell death and permanent tumor blood vessel closure | Transient liver insufficiency, ascitesHigh local recurrence rate High local recurrence rate | |
ECT Light-activated drug therapy | |||
TACE | Tumor necrosis | High rate of tumor recurrence in patients |